NEW YORK (GenomeWeb News) – Affymetrix said in a regulatory filing this week that all eight of its nominees have been elected to its board of directors by the firm's shareholders. The board includes Stephen Fodor, Frank Witney, Nelson Chan, John Diekman, Gary Guthart, Jami Dover Nachtsheim, Robert Trice, and Robert Wayman.
Fodor is founder and executive chairman of the firm, while Witney is CEO and president. Wayman was elected by the independent directors to serve as lead director.
Waters said in a regulatory filing this week that its board of directors has been re-elected by shareholders. The board includes President, CEO and Chairman Douglas Berthiaume, Joshua Bekenstein, Michael Berendt, Edward Conard, Laurie Glimcher, Christopher Kuebler, William Miller, JoAnn Reed, and Thomas Salice.
IntegenX has appointed David Smith to serve as its new COO. Smith most recently served as CFO of Thoratec, and previous to that was CFO at Chiron. He currently is chair of the audit committee and a director of OncoGenex Pharmaceuticals and previously was chair of the audit committee and a director of Perlegen Sciences.
Vermillion said this week that President and CEO Gail Page will be leaving the company by September and the firm has begun the process to find her successor. Page also has resigned her seat on the board of directors, and effective immediately Vermillion amended its bylaws to eliminate the vacant seat, reducing its board from seven to six members.
Luminex said that Gerard Vaillant has stepped down from the board of directors of Luminex, effective immediately, the firm said in an SEC filing Thursday. He resigned to focus his efforts on his roles as acting CEO and member of the board of directors of Tecan.
In addition, Luminex said that its shareholders have elected President and CEO Patrick Blathrop, G. Walter Loewenbaum, Kevin McNamara, and Edward Ogunro to serve as class III directors for a term of three years.
Marc Olesen has been appointed president and COO of DNAnexus, the firm said this week. He most recently was SVP and GM of network and cloud security for McAfee. He also previously was a VP of software-as-a-service for Mercury Interactive, which was acquired by Hewlett-Packard.
HTG Molecular Diagnostics has hired Chris Roberts to serve as VP of medical innovation. Roberts joins HTG from Caris Life Science, where he was VP of the oncology division. Previous to that, he worked at Ventana Medical Ssystems as a director in the molecular diagnostic and strategic marketing divisions.
Bruker said that its shareholders have elected four directors to serve until the firm's 2015 annual meeting of stockholders: Richard Kniss, Joerg Laukien, William Linton, and Chris van Ingen.
Earlier this week, Bruker urged against a recommendation from ISS Corporate Services that shareholders withhold votes for Kniss and Linton. According to a Bruker regulatory filing Friday, nearly 62 million votes were withheld for Kniss and Linton each, but more than 77 million votes were in favor of their re-election to the board.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.